Anthraquinone

Anthraquinone

SCHEMBL29358690

O=C1c2ccccc2C(=O)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 1.00
▸ KMT2A Q03164 3/20 1.00
▸ CDC25B P30305 3/20 1.00
▸ MAOA P21397 5/20 0.79
▸ RAB9A P51151 4/20 0.79
▸ APAF1 O14727 3/20 0.79
▸ SMN1; SMN2 Q16637 3/20 0.79
▸ POLB P06746 3/20 0.79
▸ MAPT P10636 3/20 0.79
▸ TDP2 O95551 2/20 0.79
▸ KDM4E B2RXH2 2/20 0.79
▸ LMNA P02545 2/20 0.79
▸ S100A4 P26447 2/20 0.79
▸ BLM P54132 2/20 0.79
▸ NPC1 O15118 2/20 0.79
▸ MAPK1 P28482 2/20 0.79
▸ CES2 O00748 1/20 0.79
▸ TERT O14746 1/20 0.79
▸ PLIN1 O60240 1/20 0.79
▸ S1PR4 O95977 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthraquinone SCHEMBL1901249 1.00 MEN1 (1.00) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL14943 1.00 MEN1 (1.00) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL7776458 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL17005080 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL11421894 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL9178171 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL445193 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL808446 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A
SCHEMBL20203661 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A
Anthraquinone SCHEMBL2256315 0.96 MEN1 (0.92) MEN1KMT2ACDC25BMAOARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 852 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104062-A1 METHOD FOR OBTAINING CARBON DIOXIDE DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT (DE) 2026-05-21 — — WO claimed
EP-4037900-B1 LED ILLUMINATION ELEMENTS BASED ON MULTILAYER BODIES WITH SOLID STONE APPEARANCE COVESTRO DEUTSCHLAND AG (DE) 2026-05-06 — — EP claimed
EP-3924448-B1 CELLULOSE-BASED SEPARATORS COMPRISING FLAME RETARDANT, AND USES THEREOF IN ELECTROCHEMISTRY HYDRO QUEBEC (CA) 2026-04-15 — — EP claimed
US-12599322-B2 Method for an analyte sensor cover-membrane preparation ROCHE DIABETES CARE, INC. (US) 2026-04-14 — — US claimed
EP-4370614-B1 DISPERSANTS FOR THE WATER-BORNE DISPERSION OF PIGMENTS, COMPOSITION THEREOF, AND THE METHOD FOR PREPARING THE SAME CLARIANT INT LTD (CH) 2026-03-11 — — EP claimed
WO-2026047185-A1 AGENT FOR DYEING KERATIN FIBERS DR. KURT WOLFF GMBH & CO. KG (DE) 2026-03-05 — — WO claimed
EP-4702969-A1 AGENT FOR DYEING KERATIN FIBRES Dr. Kurt Wolff GmbH & Co. KG (DE) 2026-03-04 — — EP claimed
EP-4702967-A1 CONDITIONER FOR KERATIN FIBRES Dr. Kurt Wolff GmbH & Co. KG (DE) 2026-03-04 — — EP claimed
EP-4165465-B1 SYSTEMS AND METHODS FOR INDICATING THE TIME ELAPSED SINCE THE OCCURRENCE OF A TRIGGERING EVENT JOHNSON & JOHNSON VISION CARE (US) 2026-02-18 — — EP claimed
EP-3723820-B1 SILICONE POLYUREA BLOCK COPOLYMER COATING COMPOSITIONS AND METHODS INNOVATIVE SURFACE TECH INC (US) 2026-02-11 — — EP claimed
EP-3031866-B1 METHOD FOR PRODUCING HALOGENATED ORGANIC PIGMENT, HALOGENATED ORGANIC PIGMENT PRODUCED BY SAID PRODUCTION METHOD, AND COLORED COMPOSITION CONTAINING SAID HALOGENATED ORGANIC PIGMENT TOYO INK SC HOLDINGS CO LTD (JP) 2022-05-04 — — EP claimed
EP-3626807-B1 BIOREFINING OF CRUDE TALL OIL SUNPINE AB (SE) 2022-04-20 — — EP claimed
EP-3980499-A1 PRESERVATIVE-FREE PIGMENT PASTE Brillux GmbH & Co. KG (DE) 2022-04-13 — — EP claimed
EP-3701015-B1 AMPLIFICATION NANOSWITCH SYSTEM BASED ON SPLIT SITE-SPECIFIC CLEAVING ENZYMES FOR THE IN VITRO DETECTION OF TARGET ANALYTES AND METHOD FOR THE DETECTION OF SAID TARGET ANALYTES ULISSE BIOMED S P A (IT) 2022-04-06 — — EP claimed
EP-3746489-B1 PHOTOLABILE BARBITURATE COMPOUNDS 3M INNOVATIVE PROPERTIES CO (US) 2022-03-30 — — EP claimed
EP-3504017-B1 COLOURED CURABLE COMPOSITION FOR ADDITIVE MANUFACTURING PROCESSES, 3-DIM COMPOSITE ARTICLE AND USE THEREOF 3M INNOVATIVE PROPERTIES CO (US) 2022-03-30 — — EP claimed
WO-2022058130-A1 KIT FOR PRODUCING A COATING COMPOUND BRILLUX GMBH & CO. KG (DE) 2022-03-24 — — WO claimed
CN-112794983-B Preparation method of visible light cured self-repairing fluorine-containing polyurethane resin 常州大学 2022-03-04 — — CN claimed
US-20220054059-A1 METHOD FOR AN ANALYTE SENSOR COVER-MEMBRANE PREPARATION ROCHE DIABETES CARE, INC. 2022-02-24 — — US claimed
EP-2623974-B1 SENSOR, SENSOR SYSTEM, AND SENSOR MANUFACTURE PROCESS PHC HOLDINGS CORP (JP) 2022-02-16 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12599322-B2 Method for an analyte sensor cover-membrane preparation F10, S100A10, EPCAM MEN1 946/4885KMT2A 3684/4885CDC25B 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback